A two-peptide research blend with 500 mcg of BPC-157 and 500 mcg of TB-500 per capsule. Each bottle contains 60 capsules and is supplied for laboratory and analytical research only.
For laboratory research use only. Not for human or veterinary use.
Wolverine combines BPC-157 and TB-500 in one capsule. The listed amount is 500 mcg of each peptide per capsule.
Preclinical research has examined BPC-157, TB-500, and their combination in experimental tendon and soft-tissue models. These studies describe research areas; they do not establish effects for this product.
| Compound | Per capsule | Total in 60ct bottle |
|---|---|---|
| BPC-157 | 500 mcg (0.5 mg) | 30 mg |
| TB-500 | 500 mcg (0.5 mg) | 30 mg |
| Combined total | 1,000 mcg (1 mg) | 60 mg |
Quantified to verify concentration within accepted labeled specification.
Assessed for peptide purity and absence of significant impurities by analytical methods.
Confirmed by analytical testing to match reference peptide characteristics.
Batch records and test data maintained for traceability and transparency.
Each capsule contains 500 mcg of BPC-157 and 500 mcg of TB-500, for 1,000 mcg combined.
At 60 capsules, the bottle contains 30 mg of BPC-157 and 30 mg of TB-500, for 60 mg combined.
Preclinical studies have investigated these peptides in experimental models, including tendon research.
